Term. This Agreement shall commence on the date hereof and shall terminate, except to the extent that any obligation of the Company hereunder remains unpaid as of such time, upon the earliest of # three (3) years from the date hereof; # the termination of the Executive’s employment with the Company based on death, “Disability” (as defined in Section 3(b)), “Mandatory Retirement” (as defined in Section 3(c)) or “Cause” (as defined in Section 3(d)) or by the Executive other than for “Good Reason” (as defined in Section 3(e)); and # two (2) years from the date of a “Change in Control of the Company” (as defined in Section 2) if the Executive is employed by the Company as of such time. The three (3) year period referred to in item # above shall automatically be extended for an additional year on each anniversary date of this Agreement to renew the three year period referred to in item # above, unless the Company gives written notice to the contrary to the Executive at least thirty (30) days prior to such anniversary date; provided that the Company may not deliver a notice of nonrenewal after # a Potential Change in Control (as defined in Section 2 hereof) unless the Board of Directors of the Company (the “Board”) has adopted a Nullification Resolution (as defined in Section 2 hereof) with respect to such Potential Change in Control or # a Change in Control (as defined in Section 2 hereof).

Term. The Company hereby employs Executive, and Executive hereby accepts such employment, for a term (the “Term”) commencing on July 3, 2017 and continuing in effect until terminated by either the Company or Executive. Executive’s employment with the Company shall be “at will,” meaning that Executive’s employment may be terminated by the Company or Executive at any time for any reason. Any termination of the Term by the Company or Executive shall be effective as specified in a written notice from the terminating party to the other party; provided that the effective date specified in the written notice following Executive’s resignation shall not be less than 45 days after the date that written notice is provided by Executive to the Company, unless otherwise determined in the sole discretion of the Board of Directors (the “Board”) of the Company.

Term. The term of this Agreement shall commence on January 1, 2017 (the "Effective Date") and end on December 31, 2018 (the "Expiration Date"), unless terminated earlier as provided herein. The period of time from the Effective Date through the Expiration Date or earlier termination of this Agreement is referred to herein as the "Term." The Term shall automatically end upon termination of [[Mr. Kanas:Person]]' services hereunder.

Term. The Plan shall generally be effective as of the Effective Date, subject to amendment from time to time in accordance with Section 8.2. The Plan shall continue until terminated pursuant to Article 8 of the Plan.

Term. The Committee shall establish the term of each Option in the Participant’s Award Agreement. The term of an Option shall not be longer than ten (10) years from the Date of Grant, except that an Incentive Stock Option granted to a 10% Shareholder shall not have a term in excess of five (5) years. No Option may be exercised after the expiration of its term or, except as set forth in the Participant’s Award Agreement, after the termination of the Participant’s employment with the Company and/or its Affiliates.

Term. The period of Executive’s employment under this Agreement shall commence on the Effective Date and shall continue until Executive’s employment with the Company is terminated pursuant to Section 5. The phrase “Term” as used in this Agreement shall refer to the entire period of employment of Executive by the Company.

Term. This Agreement shall commence on the Effective Date and shall end on the fifth (5th) anniversary of the Effective Date and shall automatically renew for one additional two (2) year period unless either Party provide written notice of non-renewal at least two (2) years prior to the fifth anniversary of the Effective Date or the Agreement is terminated earlier as provided herein (the “Term”). Notwithstanding the foregoing, each Project Plan may have separate term and termination provisions so long as the term of any Project Plan does not extend beyond the Term.

TERM. This Agreement is effective as of the date hereof and shall terminate, except to the extent that any obligation remains unpaid as of such time, upon the earliest of the following:

Term. This Agreement will commence as of the Effective Date and, unless sooner terminated in accordance with the terms hereof, will continue in effect until the expiration of Zai Lab’s royalty obligations to GSK under Section 4.3 in all countries in the Territory (the “Term”). However, effective upon the expiration of Zai Lab’s royalty obligations to GSK with respect to a given Product in a given country or in the Territory, Zai Lab and its Affiliates, licensee and sublicensees shall have the right to continue to Commercialize the relevant Product in such country without further obligation to GSK.

Term. The term of this Agreement (the “Term”) shall commence on the Effective Date and, unless sooner terminated by mutual agreement or pursuant to any other provision of this Agreement, shall terminate on the date on which all obligations under this Agreement between the Parties with respect to the payment of milestones or royalties with respect to Licensed Products have passed or expired.